Cargando…
Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort
BACKGROUND: In current care, patients’ personal and self-reported family histories are primarily used to determine whether genetic testing for hereditary endocrine tumor syndromes (ETS) is indicated. Population genomic screening for other conditions has increased ascertainment of individuals with pa...
Autores principales: | Savatt, Juliann M., Ortiz, Nicole M., Thone, Gretchen M., McDonald, Whitney S., Kelly, Melissa A., Berry, Alexander S. F., Alvi, Madiha M., Hallquist, Miranda L. G., Malinowski, Jennifer, Purdy, Nicholas C., Williams, Marc S., Sturm, Amy C., Buchanan, Adam H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172012/ https://www.ncbi.nlm.nih.gov/pubmed/35668420 http://dx.doi.org/10.1186/s12916-022-02375-4 |
Ejemplares similares
-
Experience Completing Population Screening for Variants Associated With Endocrine Tumor Syndromes in a Large, Healthcare-Based Cohort
por: Savatt, Juliann M, et al.
Publicado: (2021) -
A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System
por: Jones, Laney K., et al.
Publicado: (2022) -
Genetic Testing in Neurodevelopmental Disorders
por: Savatt, Juliann M., et al.
Publicado: (2021) -
Testing and Management of Iron Overload After Genetic Screening–Identified Hemochromatosis
por: Savatt, Juliann M., et al.
Publicado: (2023) -
Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort
por: Schiabor Barrett, Kelly M., et al.
Publicado: (2022)